← Back to Search

Corticosteroid

Triamcinolone 10mg/mL for Trigger Finger

Phase 4
Waitlist Available
Led By Sebastian Lalonde, MD
Research Sponsored by University of Missouri-Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least one symptomatic trigger finger
Patients recommended to receive corticosteroid injections
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month
Awards & highlights

Study Summary

This trial is testing whether a higher concentration of a particular steroid is more effective in treating trigger finger than a lower concentration of the same steroid or a different steroid.

Eligible Conditions
  • Trigger Finger

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have at least one finger that is causing you discomfort and difficulty in movement.
Select...
You have been advised to get corticosteroid injections.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Disabilities of the Arm, Shoulder and Hand (DASH)
Trigger Finger Disorder
Pain Visual Analog Score (VAS)
+1 more

Trial Design

3Treatment groups
Active Control
Group I: Triamcinolone 10mg/mLActive Control1 Intervention
A corticosteroid injection of Triamcinolone 10mg/mL will be given to subjects to treat their symptoms of trigger finger.
Group II: Soluble dexamethasone 4mg/mLActive Control1 Intervention
A corticosteroid injection of Soluble Dexamethasone 4mg/mL will be given to subjects to treat their symptoms of trigger finger.
Group III: Triamcinolone 40mg/mLActive Control1 Intervention
A corticosteroid injection of Triamcinolone 40mg/mL will be given to subjects to treat their symptoms of trigger finger.

Find a Location

Who is running the clinical trial?

University of Missouri-ColumbiaLead Sponsor
360 Previous Clinical Trials
627,844 Total Patients Enrolled
Sebastian Lalonde, MDPrincipal InvestigatorUniversity of Missouri-Columbia
1 Previous Clinical Trials
13 Total Patients Enrolled
Jay Bridgeman, MDPrincipal InvestigatorUniversity of Missouri-Columbia
1 Previous Clinical Trials
13 Total Patients Enrolled

Media Library

Dexamethasone 4 mg/ml (Corticosteroid) Clinical Trial Eligibility Overview. Trial Name: NCT04002037 — Phase 4
Trigger Finger Research Study Groups: Triamcinolone 10mg/mL, Soluble dexamethasone 4mg/mL, Triamcinolone 40mg/mL
Trigger Finger Clinical Trial 2023: Dexamethasone 4 mg/ml Highlights & Side Effects. Trial Name: NCT04002037 — Phase 4
Dexamethasone 4 mg/ml (Corticosteroid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04002037 — Phase 4
Trigger Finger Patient Testimony for trial: Trial Name: NCT04002037 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any precedent studies involving Soluble dexamethasone 4mg/mL?

"Currently, 589 clinical trials are exploring the efficacy of Soluble dexamethasone 4mg/mL with 150 in Phase 3. While most of these studies take placein Mishawaka, Indiana, there is an expansive pool of 18711 other locations running similar experiments."

Answered by AI

Has the FDA authorized Soluble dexamethasone 4mg/mL for use?

"Our team at Power rated Soluble dexamethasone 4mg/mL a 3 on the safety scale, as this medication has already been approved and is in its final trial phase."

Answered by AI

How many individuals are currently participating in this clinical trial?

"Affirmative. Based on the information hosted by clinicaltrials.gov, this medical research is still recruiting participants and was first posted in June of 2019 with a most recent update November 22nd 2021. Seekers need to find 200 patients at one site for enrollment into the trial."

Answered by AI

What maladies can be remedied by Soluble dexamethasone 4mg/mL?

"Soluble dexamethasone 4mg/mL is a commonly prescribed medication for synovitis, however it can also be of benefit to those dealing with ophthalmia, sympathetic symptoms, branch retinal vein occlusion and communicable diseases."

Answered by AI

Is this trial accepting new participants currently?

"Per the clinicaltrials.gov registry, this research initiative is actively seeking participants. It was first listed on June 25th 2019 and updated November 22nd 2021."

Answered by AI

Who else is applying?

What state do they live in?
Missouri
What site did they apply to?
University of Missouri Health Care
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

To stop the pain.
PatientReceived no prior treatments
~21 spots leftby Mar 2025